| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $81.4M | +14.9% |
| Cost of Revenue | $5.8M | -2.5% |
| R&D Expense | $104.0M | -5.1% |
| SG&A Expense | $36.6M | -12.7% |
| Operating Income | -$121.5M | +7.0% |
| Interest Expense | $16.3M | -67.6% |
| Pre-tax Income | -$141.6M | +9.3% |
| Income Tax | $1.0M | +511.4% |
| Net Income | -$142.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $261.3M | +4.2% |
| Accounts Receivable | $29.1M | +43.3% |
| Inventory | $4.2M | -77.2% |
| Current Assets | $306.3M | -0.3% |
| Total Assets | $323.1M | +0.4% |
| Current Liabilities | $70.2M | -12.8% |
| Total Liabilities | $509.0M | -3.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$141.2M | -14.0% |
| Capital Expenditures | $264K | -69.6% |
| Investing Cash Flow | $395K | +145.6% |
| Financing Cash Flow | $150.9M | +55.5% |
| Free Cash Flow | -$141.4M | -13.4% |
| +9.6% |
| EPS (Basic) | -$1.12 | +30.9% |
| EPS (Diluted) | -$1.12 | +30.9% |
| Stockholders' Equity |
| -$185.8M |
| +8.3% |